<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37964352</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-7364</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>14</Day></PubDate></JournalIssue><Title>Human genomics</Title><ISOAbbreviation>Hum Genomics</ISOAbbreviation></Journal><ArticleTitle>Identification of genetic loci jointly influencing COVID-19 and coronary heart diseases.</ArticleTitle><Pagination><StartPage>101</StartPage><MedlinePgn>101</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40246-023-00547-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Comorbidities of coronavirus disease 2019 (COVID-19)/coronary heart disease (CHD) pose great threats to disease outcomes, yet little is known about their shared pathology. The study aimed to examine whether comorbidities of COVID-19/CHD involved shared genetic pathology, as well as to clarify the shared genetic variants predisposing risks common to COVID-19 severity and CHD risks.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">By leveraging publicly available summary statistics, we assessed the genetically determined causality between COVID-19 and CHD with bidirectional Mendelian randomization. To further quantify the causality contributed by shared genetic variants, we interrogated their genetic correlation with the linkage disequilibrium score regression method. Bayesian colocalization analysis coupled with conditional/conjunctional false discovery rate analysis was applied to decipher the shared causal single nucleotide polymorphisms (SNPs).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Briefly, we observed that the incident CHD risks post COVID-19 infection were partially determined by shared genetic variants. The shared genetic variants contributed to the causality at a proportion of 0.18 (95% CI 0.18-0.19) to 0.23 (95% CI 0.23-0.24). The SNP (rs10490770) located near LZTFL1 suggested direct causality (SNPs &#x2192; COVID-19 &#x2192; CHD), and SNPs in ABO (rs579459, rs495828), ILRUN(rs2744961), and CACFD1(rs4962153, rs3094379) may simultaneously influence COVID-19 severity and CHD risks.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Five SNPs located near LZTFL1 (rs10490770), ABO (rs579459, rs495828), ILRUN (rs2744961), and CACFD1 (rs4962153, rs3094379) may simultaneously influence their risks. The current study suggested that there may be shared mechanisms predisposing to both COVID-19 severity and CHD risks. Genetic predisposition to COVID-19 is a causal risk factor for CHD, supporting that reducing the COVID-19 infection risk or alleviating COVID-19 severity among those with specific genotypes might reduce their subsequent CHD adverse outcomes. Meanwhile, the shared genetic variants identified may be of clinical implications for identifying the target population who are more vulnerable to adverse CHD outcomes post COVID-19 and may also advance treatments of 'Long COVID-19.'</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Siyue</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Hexiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, PLA Rocket Force Characteristic Medical Center, Beijing, 100088, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunfang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Public Health, Baotou Medical College, Baotou, 014040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Qiwen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China National Center for Bioinformation, Beijing, 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mengying</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiating</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Enci</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xueheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xueying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yiqun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Local Diseases Control and Prevention, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, 350001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dafang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yonghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China. yhhu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China. twu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. BX2021021</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>No. 2020CXB009</GrantID><Agency>Fujian Provincial Health Technology Project</Agency><Country/></Grant><Grant><GrantID>No. 2021J01352</GrantID><Agency>Natural Science Foundation of Fujian Province, China</Agency><Country/></Grant><Grant><GrantID>No. 8123066</GrantID><Agency>Key Project of Natural Science Funds of China</Agency><Country/></Grant><Grant><GrantID>No. 81872695</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>No. 201502006</GrantID><Agency>Special Fund for Health Scientific Research in Public Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Genomics</MedlineTA><NlmUniqueID>101202210</NlmUniqueID><ISSNLinking>1473-9542</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="Y">Coronary Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="N">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37964352</ArticleId><ArticleId IdType="pmc">PMC10647050</ArticleId><ArticleId IdType="doi">10.1186/s40246-023-00547-8</ArticleId><ArticleId IdType="pii">10.1186/s40246-023-00547-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543&#x2013;558. doi: 10.1038/s41569-020-0413-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021;21:e26&#x2013;35. doi: 10.1016/S1473-3099(20)30773-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30773-8</ArticleId><ArticleId IdType="pmc">PMC7837315</ArticleId><ArticleId IdType="pubmed">33125914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020;395:1014&#x2013;1015. doi: 10.1016/S0140-6736(20)30633-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30633-4</ArticleId><ArticleId IdType="pmc">PMC7138151</ArticleId><ArticleId IdType="pubmed">32197108</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. COVID-19: a vascular disease. Trends Cardiovasc Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo RB, Botelho BG, de Hollanda JVG, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35:1. doi: 10.1038/s41371-020-0387-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology &amp; Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021; published online Sept 16. 10.1093/CVR/CVAB298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei JF, Huang FY, Xiong TY, et al. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart. 2020;106:1154&#x2013;1159. doi: 10.1136/heartjnl-2020-317007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317007</ArticleId><ArticleId IdType="pmc">PMC7398466</ArticleId><ArticleId IdType="pubmed">32354798</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Plein S, O&#x2019;Donnell JS, Sharif K, Bridgewood C. Increased cardiovascular mortality in African Americans with COVID-19. Lancet Respir Med. 2020;8:649&#x2013;651. doi: 10.1016/S2213-2600(20)30244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30244-7</ArticleId><ArticleId IdType="pmc">PMC7255150</ArticleId><ArticleId IdType="pubmed">32473125</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 2020 doi: 10.12688/WELLCOMEOPENRES.15555.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/WELLCOMEOPENRES.15555.2</ArticleId><ArticleId IdType="pmc">PMC7384151</ArticleId><ArticleId IdType="pubmed">32760811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5:1205&#x2013;1210. doi: 10.1371/journal.pmed.0050177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050177</ArticleId><ArticleId IdType="pmc">PMC2522255</ArticleId><ArticleId IdType="pubmed">18752343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsford MJ, Gkatzionis A, Walker VM, et al. Cardiometabolic traits, sepsis, and severe COVID-19: a Mendelian randomization investigation. Circulation. 2020;142:1791. doi: 10.1161/CIRCULATIONAHA.120.050753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050753</ArticleId><ArticleId IdType="pmc">PMC7594537</ArticleId><ArticleId IdType="pubmed">32966752</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudicessi JR, Roden DM, Wilde AAM, Ackerman MJ. Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans. Heart Rhythm. 2020;17:1487&#x2013;1492. doi: 10.1016/j.hrthm.2020.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.04.045</ArticleId><ArticleId IdType="pmc">PMC7198426</ArticleId><ArticleId IdType="pubmed">32380288</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi SA, Mehrtak M, MohsseniPour M, et al. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur J Med Res. 2021 doi: 10.1186/s40001-021-00516-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00516-8</ArticleId><ArticleId IdType="pmc">PMC8135169</ArticleId><ArticleId IdType="pubmed">34016183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirinos JA, Cohen JB, Zhao L, et al. Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure. Hypertension. 2020;76:1526&#x2013;1536. doi: 10.1161/HYPERTENSIONAHA.120.15829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15829</ArticleId><ArticleId IdType="pmc">PMC10681288</ArticleId><ArticleId IdType="pubmed">32981365</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahabreh IJ, Kitsios GD, Trikalinos TA, Kent DM. The complexity of ABO in coronary heart disease. Lancet. 2011;377:1493. doi: 10.1016/S0140-6736(11)60597-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60597-7</ArticleId><ArticleId IdType="pubmed">21531266</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011;377:383&#x2013;392. doi: 10.1016/S0140-6736(10)61996-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61996-4</ArticleId><ArticleId IdType="pmc">PMC3297116</ArticleId><ArticleId IdType="pubmed">21239051</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Antonio M, Nguyen JP, Arthur TD, Matsui H, D&#x2019;Antonio-Chronowska A, Frazer KA. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Rep. 2021;37:110020. doi: 10.1016/j.celrep.2021.110020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110020</ArticleId><ArticleId IdType="pmc">PMC8563343</ArticleId><ArticleId IdType="pubmed">34762851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikpay M, Goel A, Won HH, et al. A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47:1121&#x2013;1130. doi: 10.1038/ng.3396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3396</ArticleId><ArticleId IdType="pmc">PMC4589895</ArticleId><ArticleId IdType="pubmed">26343387</ArticleId></ArticleIdList></Reference><Reference><Citation>Schunkert H, K&#xf6;nig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333&#x2013;340. doi: 10.1038/ng.784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.784</ArticleId><ArticleId IdType="pmc">PMC3119261</ArticleId><ArticleId IdType="pubmed">21378990</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658&#x2013;665. doi: 10.1002/gepi.21758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21758</ArticleId><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Smith GD, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512&#x2013;525. doi: 10.1093/ije/dyv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304&#x2013;314. doi: 10.1002/gepi.21965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig FP, Smith GD, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985&#x2013;1998. doi: 10.1093/ije/dyx102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyx102</ArticleId><ArticleId IdType="pmc">PMC5837715</ArticleId><ArticleId IdType="pubmed">29040600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, Loh PR, Finucane HK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291&#x2013;295. doi: 10.1038/ng.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni G, Moser G, Ripke S, et al. Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood. Am J Hum Genet. 2018;102:1185. doi: 10.1016/j.ajhg.2018.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2018.03.021</ArticleId><ArticleId IdType="pmc">PMC5993419</ArticleId><ArticleId IdType="pubmed">29754766</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236&#x2013;1241. doi: 10.1038/ng.3406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3406</ArticleId><ArticleId IdType="pmc">PMC4797329</ArticleId><ArticleId IdType="pubmed">26414676</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014 doi: 10.1371/JOURNAL.PGEN.1004383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PGEN.1004383</ArticleId><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreassen OA, Thompson WK, Schork AJ, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013 doi: 10.1371/JOURNAL.PGEN.1003455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PGEN.1003455</ArticleId><ArticleId IdType="pmc">PMC3636100</ArticleId><ArticleId IdType="pubmed">23637625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazal S, Weissbrod O, Hormozdiari F, et al. Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity. Nat Genet. 2022;54:827. doi: 10.1038/s41588-022-01087-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01087-y</ArticleId><ArticleId IdType="pmc">PMC9894581</ArticleId><ArticleId IdType="pubmed">35668300</ArticleId></ArticleIdList></Reference><Reference><Citation>Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352&#x2013;2371. doi: 10.1016/j.jacc.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7198856</ArticleId><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Foley CN, Zuber V. Inferring causal relationships between risk factors and outcomes from genome-wide association study data. Annu Rev Genom Hum Genet. 2018;19:303&#x2013;327. doi: 10.1146/annurev-genom-083117-021731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-083117-021731</ArticleId><ArticleId IdType="pmc">PMC6481551</ArticleId><ArticleId IdType="pubmed">29709202</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483&#x2013;495. doi: 10.1038/nrg3461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3461</ArticleId><ArticleId IdType="pmc">PMC4104202</ArticleId><ArticleId IdType="pubmed">23752797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez Cordero AI, Li X, Milne S, et al. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19. Hum Genet. 2021;140:969&#x2013;979. doi: 10.1007/s00439-021-02264-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-021-02264-5</ArticleId><ArticleId IdType="pmc">PMC7892327</ArticleId><ArticleId IdType="pubmed">33604698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Balmat TJ, Antonia AL, et al. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility. Genome Med. 2021 doi: 10.1186/S13073-021-00904-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13073-021-00904-Z</ArticleId><ArticleId IdType="pmc">PMC8127495</ArticleId><ArticleId IdType="pubmed">34001247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S, Rheinstein PH. ABO blood groups, COVID-19 infection and mortality. Blood Cells Mol Dis. 2021 doi: 10.1016/J.BCMD.2021.102571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BCMD.2021.102571</ArticleId><ArticleId IdType="pmc">PMC8059281</ArticleId><ArticleId IdType="pubmed">33894687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo-Velasco &#xc1;, Jim&#xe9;nez Garc&#xed;a MT, S&#xe1;nchez Rodr&#xed;guez A, Hijas Villaizan M, Carretero G&#xf3;mez J, Miramontes-Gonz&#xe1;lez JP. Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2. Med Clin. 2021 doi: 10.1016/J.MEDCLI.2021.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEDCLI.2021.06.017</ArticleId><ArticleId IdType="pmc">PMC9240948</ArticleId><ArticleId IdType="pubmed">35784826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Zhu P, Shen Q, Jin L. Prospective association of a genetic risk score with major adverse cardiovascular events in patients with coronary artery disease. Medicine. 2017 doi: 10.1097/MD.0000000000009473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000009473</ArticleId><ArticleId IdType="pmc">PMC5758289</ArticleId><ArticleId IdType="pubmed">29390587</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb TR, Erdmann J, Stirrups KE, et al. Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease. J Am Coll Cardiol. 2017;69:823&#x2013;836. doi: 10.1016/j.jacc.2016.11.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.11.056</ArticleId><ArticleId IdType="pmc">PMC5314135</ArticleId><ArticleId IdType="pubmed">28209224</ArticleId></ArticleIdList></Reference><Reference><Citation>Winther-Larsen A, Christiansen MK, Larsen SB, et al. The ABO locus is associated with increased fibrin network formation in patients with stable coronary artery disease. Thromb Haemost. 2020;120:1246&#x2013;1256. doi: 10.1055/s-0040-1713753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1713753</ArticleId><ArticleId IdType="pubmed">32604426</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardlie KG, DeLuca DS, Segr&#xe8; AV, et al. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648&#x2013;660. doi: 10.1126/science.1262110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1262110</ArticleId><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference><Reference><Citation>Morsy S, Morsy A. Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins. J Mol Graph Model. 2021 doi: 10.1016/J.JMGM.2021.107836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JMGM.2021.107836</ArticleId><ArticleId IdType="pmc">PMC7859657</ArticleId><ArticleId IdType="pubmed">33588349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemmati D, Tisato V. Genetic hypothesis and pharmacogenetics side of renin-angiotensin-system in COVID-19. Genes (Basel) 2020;11:1&#x2013;17. doi: 10.3390/genes11091044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11091044</ArticleId><ArticleId IdType="pmc">PMC7563402</ArticleId><ArticleId IdType="pubmed">32899439</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudoin CA, Hamaia SW, Huang CLH, Blundell TL, Jackson AP. Can the SARS-CoV-2 spike protein bind integrins independent of the RGD sequence? Front Cell Infect Microbiol. 2021 doi: 10.3389/FCIMB.2021.765300.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCIMB.2021.765300</ArticleId><ArticleId IdType="pmc">PMC8637727</ArticleId><ArticleId IdType="pubmed">34869067</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes DJ, Cross AR, Hua P, et al. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet. 2021;53:1606&#x2013;1615. doi: 10.1038/s41588-021-00955-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00955-3</ArticleId><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Clohisey S, Klaric L, et al. Genetic mechanisms of critical illness in COVID-19. Nature. 2021;591:92&#x2013;98. doi: 10.1038/s41586-020-03065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03065-y</ArticleId><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T, Pigazzini S, Degenhardt F, et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Investig. 2021 doi: 10.1172/jci152386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci152386</ArticleId><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu-Ray I, Almaddah N k., Adeboye A, Soos MP. Cardiac Manifestations of Coronavirus (COVID-19). StatPearls 2023; published online Jan 9. https://www.ncbi.nlm.nih.gov/books/NBK556152/ (accessed Oct 2, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">32310612</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819&#x2013;824. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129&#x2013;133. doi: 10.1016/j.ijid.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.06.015</ArticleId><ArticleId IdType="pmc">PMC7110556</ArticleId><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451&#x2013;1454. doi: 10.1038/s41418-020-0530-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0530-3</ArticleId><ArticleId IdType="pmc">PMC7091918</ArticleId><ArticleId IdType="pubmed">32205856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41:1798&#x2013;1800. doi: 10.1093/eurheartj/ehaa231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa231</ArticleId><ArticleId IdType="pmc">PMC7454513</ArticleId><ArticleId IdType="pubmed">32186331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>